T-Mobile stock hits 52-week low at 147.89 USD
Source: Investing.com

T-Mobile shares reached a 52-week low of $147.89, down 32.02% over the past year and 34.5% from the $225.93 high, though the company remains profitable at $9.54 in trailing-12-month EPS. Analysts offered mixed views ahead of the October 28 earnings report: Raymond James upgraded to Outperform and KeyBanc and StoneX reiterated positive ratings, while JPMorgan cut its target to $260 from $275 and slightly lowered revenue estimates, aligning with $19.30 billion in wireless service revenue guidance.
Analysis
The setup is a near-term test of whether pricing can lift monetization without accelerating customer losses. For the October 28 report, the key read-through is the joint direction of service-revenue growth, ARPA and post-pricing churn—not any one metric in isolation. If ARPA improves while churn stays contained, the selloff may have priced in too much competitive damage; if churn worsens without corresponding monetization, estimates and the valuation case remain vulnerable.
SpaceX is a credible longer-horizon risk mainly where satellite connectivity can substitute for coverage in remote areas or serve as a complement to terrestrial plans. That is not equivalent to replacing T-Mobile’s urban capacity or full-service mobile offering; near-term impact depends on product launch, economics, regulatory permissions and distribution. Verizon and AT&T could also face the same substitution, so satellite competition is not automatically a relative disadvantage for TMUS.
The reported low price and third-party “undervalued” label do not establish intrinsic value. Near term, earnings guidance and churn disclosures dominate; over 1–3 months, revisions to subscriber and service-revenue expectations matter more than analyst ratings. Over 6–18 months, the structural question is whether satellite connectivity pressures pricing or instead expands coverage and supports bundled-plan retention. The thesis weakens if churn rises while ARPA fails to offset it, or management lowers service-revenue expectations; it improves if monetization holds with stable customer trends.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.25
Ticker Sentiment
Key Decisions for Investors
- Avoid chasing the drawdown before the October 28 report. Treat the release as a catalyst and monitor ARPA, churn, and wireless service-revenue guidance together; a favorable signal requires monetization gains without a material deterioration in customer retention.
- Watch TMUS for a post-earnings entry only if guidance and customer metrics stabilize. The asymmetric risk is further estimate compression if pricing actions are buying revenue at the cost of churn; the upside case is a sentiment reset if that trade-off proves better than feared.
- Keep SpaceX-related competitive risk as a 6–18 month monitoring item, not a standalone short thesis today. Verify launch timing, regulatory status, service economics and evidence of customer substitution before positioning around it.
- Do not rely on the platform’s undervaluation label or analyst target changes as a catalyst. Reassess after earnings revisions and price action; a continued decline alongside weaker churn/ARPA outcomes would falsify the stabilization case.
More News
- Next week brings major risks for the stock market, just as the AI trade keeps faltering
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- OpenAI Moves Toward a $1.25 Trillion Value
- Investing.com’s stocks of the week
- Elon Musk’s dangerous grip on outer space
- After previous day’s slump, trading is quieter among AI shares
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- The $4.7 Trillion Bet: When Does AI Capex Become AI Revenue?
- Equity Research Automation Statistics: A 2026 Evidence Check